Literature DB >> 1849234

Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

I C Hsu1, R A Metcalf, T Sun, J A Welsh, N J Wang, C C Harris.   

Abstract

Human hepatocellular carcinomas (HCC) from patients in Qidong, an area of high incidence in China, in which both hepatitis B virus and aflatoxin B1 are risk factors, were analysed for mutations in p53, a putative tumour-suppressor gene. Eight of the 16 HCC had a point mutation at the third base position of codon 249. The G----T transversion in seven HCC DNA samples and the G----C transversion in the other HCC are consistent with mutations caused by aflatoxin B1 in mutagenesis experiments. No mutations were found in exons 5,6,8 or the remainder of exon 7. These results contrast with p53 mutations previously reported in carcinomas and sarcomas of human lung, colon, oesophagus and breast; these are primarily scattered over four of the five evolutionarily conserved domains, which include codon 249 (refs 4-9). We suggest that the mutant p53 protein may be responsible for a selective clonal expansion of hepatocytes during carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849234     DOI: 10.1038/350427a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  291 in total

Review 1.  Soft tissue sarcomas and p53 mutations.

Authors:  H Taubert; A Meye; P Würl
Journal:  Mol Med       Date:  1998-06       Impact factor: 6.354

2.  Aflatoxin sufferer and p53 gene mutation in hepatocellular carcinoma.

Authors:  Zhuo-Lin Deng; Yun Ma
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

3.  The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.

Authors:  Hu Liu; Yuan Wang; Qing Zhou; Shu-Yu Gui; Xu Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

4.  An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspot.

Authors:  W R Kobertz; D Wang; G N Wogan; J M Essigmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

5.  Singlet oxygen induced mutation spectrum in mammalian cells.

Authors:  R C de Oliveira; D T Ribeiro; R G Nigro; P Di Mascio; C F Menck
Journal:  Nucleic Acids Res       Date:  1992-08-25       Impact factor: 16.971

6.  Suppression of human nasopharyngeal carcinoma cell growth in nude mice by the wild-type p53 gene.

Authors:  W Chen; Y Lee; H Wang; G G Yu; W Jiao; W Zhou; Y Zeng
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 7.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

8.  Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China.

Authors:  Zongtang Sun; Taoyang Chen; Snorri S Thorgeirsson; Qimin Zhan; Jianguo Chen; Ju-Hyun Park; Peixin Lu; Chu Chieh Hsia; Nengjin Wang; Libin Xu; Lingling Lu; Fei Huang; Yuanrong Zhu; Jianhua Lu; Zhengping Ni; Qinan Zhang; Yuying Wu; Guoting Liu; Zhiyuan Wu; Chunfeng Qu; Mitchell H Gail
Journal:  Carcinogenesis       Date:  2013-01-14       Impact factor: 4.944

9.  Relating aromatic hydrocarbon-induced DNA adducts and c-H-ras mutations in mouse skin papillomas: the role of apurinic sites.

Authors:  D Chakravarti; J C Pelling; E L Cavalieri; E G Rogan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

10.  Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens.

Authors:  A M Pfeifer; K E Cole; D T Smoot; A Weston; J D Groopman; P G Shields; J M Vignaud; M Juillerat; M M Lipsky; B F Trump
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.